Audits are one more opportunity to demonstrate the program is working well We can only assume that audits were the focus of so much discussion at this year’s 340B Coalition Winter Conference because the changes that come with the installation of new government officials will inevitably lead to a fresh look at the 340B program. […]
Rumblings of imminent healthcare policy changes were not enough to distract attendees at this year’s J.P. Morgan Healthcare Conference 2017 from their focus on several key themes at this year’s event. Below is a list of our key takeaways from what remains one of the most significant annual healthcare business conferences. The drive to value […]
January 23, 2017 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - Despite news breaking on the first steps toward the repeal of the Affordable Care Act (ACA) and President-elect Trump’s comments on pharmaceutical manufacturers and pricing, not all was doom and gloom at the J.P. Morgan 35th Annual Healthcare Conference 2017, January 9-12, […]
In honor of National Pharmacist Day on January 12, we would like to take this time to honor the pharmacists that dedicate themselves to serving and helping our patients improve their health outcomes and lives. We greatly appreciate our pharmacists and the fact that they continually act and build upon our vision and belief in […]
January 3, 2017 – Atlanta, Georgia – One of the nation’s largest independent 340B specialty pharmacies, Curant Health, announces the launch of seven 340B clinic partnerships in January 1, 2017: Family Centers Health Care - Greenwich, Connecticut Florida Department of Health, Lee County - Fort Myers, Florida Florida Department of Health, Palm Beach County - […]
January 3, 2017 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - Every year, the business of healthcare gathers en masse at the annual J.P. Morgan Healthcare Conference. This year’s conference will be held January 9 to January 12 in San Francisco. What will we learn? What will we hear? What will be […]
It will add new tools to the life science toolbox. More patients may begin to receive more medical products than before, due to the fact that the Act includes numerous provisions meant to speed up the approval process for new drugs and devices. It supports evolution of the FDA approval process. “The bill allows for […]
December 14, 2016 - Curant Health Director of Commercial Strategy and Performance, Jake Caines, featured in Managed Healthcare Executive - Congress has approved the 21st Century Cures Act, which aims to speed federal approval of new drugs and devices as well as beef up funding of medical research. It is expected that President Obama will […]
From 2012-2015 there was a 13% increase in pharmaceutical revenue loss amounting to an estimated $637 billion globally on an annual basis. According to an updated report by CapGemini and HealthPrize Technologies, this loss is directly attributed to medication nonadherence. This persistent issue has only grown despite new healthcare stakeholder policies, programs and incentive programs. […]
December 12, 2016 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - In November CapGemini and HealthPrize Technologies updated the forward to a reissued 2012 report on pharmaceutical revenue loss due to medication nonadherence that states, “Globally, according to CMR International, pharma revenues hit $1.1 trillion in 2015, which is a 13% increase […]
